MassDevice.com +5 | The top 5 medtech stories for July 13, 2017

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Philips wins FDA nod for BlueControl psoriasis treatment device Royal Philips said today it won FDA 510(k) clearance for its BlueControl wearable light therapy designed to treat mild psoriasis. The Amsterdam-based company’s BlueControl is designed as a rechargeable, wearable device which can be comfortably used on the arms, legs, elbows and knees using adjustable straps. The company won CE Mark approval in the European Union for the device in 2015. Read more 4. Avita to seek PMA for ReCell burn indication, considers making US operations hub Avita Medical today released an update on its future plans, saying it it intends to submit an application to the FDA for Premarket Approval for its ReCell device for use in patients with severe burns and that it’s considering making the US its center of operations. The ReCell device is designed to use the patient’s own skin cells to treat a variety of skin issues, including burns, reconstructive and cosmetic procedures, the company said. Read more 3. Bigfoot Biomedical taps Abbott to collaborate on automated insulin deliver...
Source: Mass Device - Category: Medical Devices Authors: Tags: News Well Plus 5 Source Type: news